Company | Price d* | Change d* | Volume, Avg. k, d* | Market Cap. d* | Revenue | Profit Net | Earnings | Free Cash Flow | Dividend Yield | P/E | EPS | Gross Margin % | Net Margin % | ROE % | ROA % | Quick Ratio % | Shares Outstanding d* | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Drug Manufacturers—General Average | - - | - - | - - | 172,146.20 | 9,274.05 | 527.40 | 21,448.39 | 697.22 | 0.54 | 4.0631 | 0.36 | 64.3165 | 3.2983 | 0.33 | 0.22 | 90.1261 | - - | ||
Maximum | - - | - - | - - | 869,677.00 | 21,382.00 | 4,762.00 | 153,378.00 | 3,847.00 | 1.51 | 76.3636 | 2.71 | 82.5000 | 30.1200 | 4.50 | 17.51 | 350.2200 | - - | ||
Minimum | - - | - - | - - | 0.00 | 944.00 | -11,911.00 | -27,870.00 | -2,626.00 | 0.00 | -335.6404 | -5.89 | 6.4100 | -100.3900 | -12.03 | -72.23 | 0.0000 | - - | ||
BP p.l.c. BPAQF | 5.50 | 0.00 0.00% | 1 vs. 22 | 87,953.00 | 48,662.00 | 2,263.00 | 1,285.00 | 0.00 | 0.1300 | 11.1223 | 1.21 | 19.53 | 4.65 | 3.25 | 0.82 | 76.58 | 15,991.00 | ||
AstraZeneca PLC AZNCF | 163.97 | 0.00 0.00% | 0 vs. 1 | 254,201.00 | 12,622.00 | 2,179.00 | - - | - - | 1.4000 | - - | - - | 75.21 | - - | - - | - - | - - | 1,550.00 | ||
Vodafone Group Public Limited Company VODPF | 1.16 | 0.00 0.00% | 0 vs. 6 | 30,353.00 | 14,895.00 | 1,497.00 | 8,126.00 | -114,660.00 | 0.0554 | 3.7500 | 5.45 | 37.88 | 10.05 | 2.50 | 1.04 | 78.07 | 26,167.00 | ||
GSK plc GLAXF | 21.69 | 0.00 0.00% | 0 vs. 1 | 88,472.00 | 7,363.00 | 1,046.00 | 376.00 | 7,935.00 | 0.2600 | 15.5725 | 0.87 | 73.69 | 14.21 | 7.56 | 1.79 | 57.37 | 4,078.00 | ||
National Grid plc NGGTF | 13.80 | -0.20 -1.43% | 0 vs. 11 | 67,425.00 | 11,361.00 | 1,162.00 | -610.00 | 32,066.00 | 0.2900 | 9.6228 | 0.44 | 31.34 | 10.23 | 3.89 | 1.18 | 67.47 | 4,885.00 |